The election may signal a shift from transgender issues being legislated by state GOP legislators to a federal focus on the issue.

STAT's Readout LOUD podcast discusses how Trump's second term and the MAHA movement could affect FDA regulation, the ...

Trump has pledged to stop federal funding of gender-affirming care and to expel from Medicare and Medicaid any hospitals that ...

An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new review finds. FDA approves first once-weekly drug treatment regimen ...

There are several ways Trump could further limit abortion access without breaking his campaign promise not to implement a national ban, experts said.

Israel has proposed a revised system of food business licensing to ease the regulatory burden on industry and improve sanitary conditions. The Ministry of Health said the current regulation ...

The Trump campaign and other conservative groups have spent millions on anti-trans ads, setting a dangerous precedent for a ...

to the U.S. Food and Drug Administration (FDA) for vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran is ...

BERLIN--(BUSINESS WIRE)--Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for the investigational compound ...

Orphan drug status, a status designated by the Food and Drug Administration (FDA), gives companies researching cures for rare diseases a seven-year window of exclusive marketing rights post ...

In 1982 Food and Drug Administration approved Humulin, Eli Lily’s recombinant insulin made from Genentech’s specially modified bacteria. It was the first drug produced through recombinant DNA ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...